
Sign up to save your podcasts
Or


CHEST February 2026, Volume 169, Issue 2
CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST February 2026 issue, including an examination of the association between culture conversion and mortality in patients with Mycobacterium abscessus complex pulmonary disease, an investigation of the comparative effectiveness of tocilizumab vs rituximab in rheumatoid arthritis-associated interstitial lung disease, and more.
Moderator:
Peter Mazzone, MD, MPH, FCCP
By American College of Chest Physicians4.2
6262 ratings
CHEST February 2026, Volume 169, Issue 2
CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST February 2026 issue, including an examination of the association between culture conversion and mortality in patients with Mycobacterium abscessus complex pulmonary disease, an investigation of the comparative effectiveness of tocilizumab vs rituximab in rheumatoid arthritis-associated interstitial lung disease, and more.
Moderator:
Peter Mazzone, MD, MPH, FCCP

1,875 Listeners

327 Listeners

500 Listeners

36 Listeners

7 Listeners

37 Listeners

3,382 Listeners

1,148 Listeners

515 Listeners

363 Listeners

265 Listeners

438 Listeners

378 Listeners

58 Listeners

271 Listeners